Medicxi Ventures Management (Jersey) Ltd NAMS Holdings History
Medicxi Ventures Management (Jersey) Ltd's NewAmsterdam Pharma Co NV Holding Summary
As of 2025-06-30, Medicxi Ventures Management (Jersey) Ltd held 2.87 Mil shares of NewAmsterdam Pharma Co NV(NAMS), totaling $51.97 Mil. This investment constitutes 12.16% of their stock portfolio, and Medicxi Ventures Management (Jersey) Ltd now holds 2.56% of the outstanding NewAmsterdam Pharma Co NV(NAMS) stock.
The initial trade took place in 2022Q4. And since then Medicxi Ventures Management (Jersey) Ltd has made 2 purchases of NAMS, at an average price of $10.95, for a total of 2.87 Mil shares. Based on historical transaction data and NAMS's current price of $22.20, Medicxi Ventures Management (Jersey) Ltd's estimated gain on his NAMS holdings is $32.29 Mil, reflecting a 102.76% gain to date.
Medicxi Ventures Management (Jersey) Ltd NAMS ($22.20) Holding Chart
Medicxi Ventures Management (Jersey) Ltd NAMS ($22.20) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1